2012 Boston Therapeutics, a developer of complex carbohydrate therapeutics designed to treat diabetes and inflammatory diseases, yesterday reported its financial…
Alimera Sciences, a biopharmaceutical company that specializes in the research, development, and commercialization of prescription ophthalmic pharmaceuticals, announced that it…
Liberator, a leading producer of sexual health and wellness products, recently reported their Q1 2013 financials for the period ended…
GlobalWise Investments and its wholly owned subsidiary Intellinetics, an enterprise content management (“ECM”) software development, sales, and marketing company, just…
Nanosphere, a leading provider of advanced molecular diagnostics systems, announced that the U.S. Food and Drug Administration has granted 510(k)…
Yesterday, Boston Therapeutics announced that Mr. Jonathan B. Rome has been named as its Chief Operating Officer. David Platt, Ph.D.,…
Quaterra Resources today reported excellent evidence of their model for the Nieves silver property in northern Zacatecas, Mexico, as assay…
Consorteum Holdings just announced that it filed its Report on Form 10-K for the fiscal year ended June 30, 2012,…
Cardium Therapeutics, a health sciences and regenerative medicine company, today presented financial results for the third quarter, ended September 30,…
It’s an unfortunate fact of business life that good ideas, even great ideas, are a dime a dozen. There isn’t…